Key result
A 5-day restricted sodium diet reduced blood pressure but did not improve brachial artery flow-mediated dilation compared to a liberal sodium diet in hypertensive patients.
Why the study?
Vascular dysfunction often persists in hypertensive patients despite drug-induced blood pressure control, but because some antihypertensive drugs directly affect vascular function, the impact of nonpharmacological blood pressure reduction remained unclear.
Does acute nonpharmacological blood pressure reduction via sodium restriction improve vascular function in hypertensive patients?
Does acute nonpharmacological blood pressure reduction via sodium restriction improve vascular function in hypertensive patients?
Answers are grounded in this paper and cite their sources.
Acute nonpharmacological reduction of blood pressure via sodium restriction does not immediately reverse vascular dysfunction in hypertensive patients.
BACKGROUND: Vascular dysfunction, an independent risk factor for cardiovascular disease, often persists in patients with hypertension, despite improvements in blood pressure control induced by antihypertensive medications. METHODS: As some of these medications may directly affect vascular function, this study sought to comprehensively examine the impact of reducing blood pressure, by a nonpharmacological approach (5 days of sodium restriction), on vascular function in 22 hypertensive individuals (14 men/8 women, 50 ± 10 years). Following a 2-week withdrawal of antihypertensive medications, two 5-day dietary phases, liberal sodium (liberal sodium, 200 mmol/day) followed by restricted sodium (restricted sodium, 10 mmol/day), were completed. Resting blood pressure was assessed and vascular function, at both the conduit and microvascular levels, was evaluated by brachial artery flow-mediated dilation (FMD), reactive hyperemia, progressive handgrip exercise, and passive leg movement (PLM). RESULTS: Despite a sodium restriction-induced fall in blood pressure (liberal sodium: 141 ± 14/85 ± 9; restricted sodium 124 ± 12/79 ± 9 mmHg, P < 0.01 for both SBP and DBP), FMD (liberal sodium: 4.6 ± 1.8%; restricted sodium: 5.1 ± 2.1%, P = 0.27), and reactive hyperemia (liberal sodium: 548 ± 201; restricted sodium: 615 ± 206 ml, P = 0.08) were not altered. Similarly, brachial artery vasodilation during handgrip exercise was not different between conditions (liberal sodium: Δ0.36 ± 0.19 mm; restricted sodium: Δ0.42 ± 0.18 mm, P = 0.16). Lastly, PLM-induced changes in peak blood flow (liberal sodium: 5.3 ± 2.5; restricted sodium: 5.8 ± 3.6 ml/min per mmHg, P = 0.30) and the total vasodilatory response [liberal sodium: 2 (0.9-2.5) vs. restricted sodium: 1.7 (1.1-2.6) ml/min per mmHg; P = 0.5] were also not different between conditions. CONCLUSION: Thus vascular dysfunction, at both the conduit and microvascular levels, persists in patients with hypertension even when blood pressure is acutely reduced by a nonpharmacological approach.
No takes yet. Share an insight, caveat, or question.
Fermoyle et al. (2022) studied Hypertension (n=22). Restricted sodium diet vs. Liberal sodium diet (200 mmol/day) was evaluated on Brachial artery flow-mediated dilation (FMD) (p=0.27). A 5-day restricted sodium diet reduced blood pressure but did not improve brachial artery flow-mediated dilation compared to a liberal sodium diet in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: